NWI Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100,000
Closed -$77.2M 58
2024
Q4
$77.2M Buy
+100,000
New +$82.8M 3.4% 9

Other funds holding LLY

NWI Management's LLY Position: Q1 2026 in Review

NWI Management increased its Eli Lilly (LLY) stake by 3,600% in Q1 2026, buying an estimated $54.7M and bringing the position to 55,500 shares worth $51M. The position accounts for 2.9% of the portfolio, ranked #11.

NWI Management first reported a position in LLY in Q1 2023 and has held it in 10 quarters since. The position peaked at $52.5M in Q4 2023. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NWI Management held 55,500 shares of Eli Lilly worth $51M as of Q1 2026.
  • NWI Management bought 54,000 Eli Lilly shares in Q1 2026, an estimated $54.7M.
  • Eli Lilly made up 2.9% of NWI Management's portfolio in Q1 2026, its #11 holding.
  • NWI Management first reported a position in Eli Lilly in Q1 2023 and has held it in 10 quarters since.
  • NWI Management's Eli Lilly position peaked at $52.5M in Q4 2023.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NWI Management's 13F filing for Q1 2026, filed 15 May 2026.